两家公司宣布,合并后的公司更名为“tras Pharma, Inc.”,由新任首席执行官Werner Cautreels领导,将于周三在纳斯达克上市交易,股票代码为“TRAW”。
TRAW即将到来的里程碑包括在2024年下半年开始...查看全文
Onconova(ONTX)03-16 05:45
$Onconova医疗(ONTX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001415889-24-008142 Size: 8 KB 网页链接查看全文
Onconova(ONTX)02-09 05:15
$Onconova医疗(ONTX)$ 144 Report of proposed sale of securities Accession Number: 0001950047-24-000741 Act: 33 Size: 4 KB 网页链接查看全文
Onconova(ONTX)03-16 05:45
$Onconova医疗(ONTX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001415889-24-008141 Size: 8 KB 网页链接查看全文
美股滚雪球04-03 09:18
$Onconova(ONTX)$ 宣布与私人持有的生物技术公司Trawsfynydd Therapeutics进行换股收购。
两家公司宣布,合并后的公司更名为“tras Pharma, Inc.”,由新任首席执行官Werner Cautreels领导,将于周三在纳斯达克上市交易,股票代码为“TRAW”。
TRAW即将到来的里程碑包括在2024年下半年开始...查看全文
$Onconova Therapeutics, Inc.(ONTX)$ EFFECT - Notice of Effectiveness Filed: 2017-12-28 AccNo: 9999999995-17-003344 Size: 1 KB 网页链接
$Onconova Therapeutics, Inc.(ONTX)$ S-3/A [Amend] - Registration statement under Securities Act of 1933 Filed: 2017-12-21 AccNo: 0001104659-17-074595 Size: 392 KB 网页链接
$Onconova Therapeutics, Inc.(ONTX)$ S-3/A [Amend] - Registration statement under Securities Act of 1933 Filed: 2017-12-21 AccNo: 0001104659-17-074595 Size: 392 KB 网页链接
$Onconova Therapeutics, Inc.(ONTX)$ S-3 - Registration statement under Securities Act of 1933 Filed: 2017-11-20 AccNo: 0001104659-17-069666 Size: 399 KB 网页链接
$Onconova Therapeutics, Inc.(ONTX)$ 8-K - Current report Filed: 2017-11-17 AccNo: 0001104659-17-069471 Size: 24 KBItem 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing 网页链接
$Onconova Therapeutics, Inc.(ONTX)$ 8-K - Current report Filed: 2017-11-13 AccNo: 0001104659-17-067982 Size: 204 KBItem 8.01: Other EventsItem 9.01: Financial Statements and Exhibits 网页链接
$Onconova Therapeutics, Inc.(ONTX)$ 424B5 - Prospectus [Rule 424(b)(5)] Filed: 2017-11-13 AccNo: 0001104659-17-067981 Size: 425 KB 网页链接
$Onconova Therapeutics, Inc.(ONTX)$ 10-Q - Quarterly report [Sections 13 or 15(d)] Filed: 2017-11-09 AccNo: 0001104659-17-067204 Size: 5 MB 网页链接
$Onconova Therapeutics, Inc.(ONTX)$ 8-K - Current report Filed: 2017-11-09 AccNo: 0001104659-17-067202 Size: 159 KBItem 2.02: Results of Operations and Financial ConditionItem 9.01: Financial Statements and Exhibits 网页链接
$Onconova Therapeutics, Inc.(ONTX)$ 美东时间 2017-11-09 盘前 披露财报,预期EPS -0.66 网页链接